ArticlePediatric cardiology2026
International Experience of Transcatheter Sinus Venosus Defect Closure in Children and Adolescents.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter closure of sinus venosus defects (SVD) is an emerging alternative to surgery, however, concerns remain regarding growth potential in paediatric patients treated with fixed-diameter stents. This retrospective study included individuals younger than 18 years from 12 centres. SVD closure was performed using covered stents after demonstration of right upper pulmonary vein redirection during balloon interrogation. Complete closure without significant residual flow was defined as procedural success. Major complications were those necessitating surgical intervention, whereas minor complications were managed intraprocedurally. Among 54 patients < 18 years, 17 had bilateral superior vena cava and six had a high-draining vein. The majority (37) underwent single-stent placement; others required multiple stents. Procedural success was 98.1%, with one embolization needing surgery. Seven needed extra stents due to migration or instability. Minor complications included arrhythmia and stent thrombus. Compared to global registry data, this cohort required smaller sheaths and fewer stents. Pulmonary vein protection and jugular-railroad techniques were frequently employed; transseptal puncture was less frequent. Over a follow-up period ranging 1-174 months, three cases of residual shunt necessitated reintervention. No late stent thrombosis was noted. One deep vein thrombosis and two instances of mild asymptomatic pulmonary vein gradients were managed conservatively. Transcatheter closure of SVD is both feasible and safe in paediatric populations. Smaller anatomical structures permitted use of single-stents through smaller sheaths, thereby streamlining the intervention. Continued long-term surveillance will be essential to further elucidate benefits in young patients. Future advancements in stent-technology and increased procedural expertise are expected to enhance outcomes.
Indexed as
Identifiers
41863591What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.